|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C12Q 1/68 | (2006.01) |
| (11) | Number of the document | 2411535 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10712629.4 |
| Date of filing the European patent application | 2010-03-24 | |
| (97) | Date of publication of the European application | 2012-02-01 |
| (45) | Date of publication and mention of the grant of the patent | 2015-06-17 |
| (46) | Date of publication of the claims translation | 2015-09-25 |
| (86) | Number | PCT/US2010/028459 |
| Date | 2010-03-24 |
| (87) | Number | WO 2010/111361 |
| Date | 2010-09-30 |
| (30) | Number | Date | Country code |
| 162848 P | 2009-03-24 | US |
| (72) |
COHEN, Nadine, US
FAVIS, Reyna, US
LI, Qingqin, US
RICCI, Deborah, US
SUN, Yu, US
VAN DE VELDE, Helgi, BE
|
| (73) |
Janssen Pharmaceutica, N.V.,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Biologiniai žymenys, skirti periferinės neuropatijos atsako į gydymą proteosomos inhibitoriumi nustatymui |
| BIOMARKERS FOR ASSESSING PERIPHERAL NEUROPATHY RESPONSE TO TREATMENT WITH A PROTEASOME INHIBITOR |
| Payment date | Validity (years) | Amount | |
| 2018-02-23 | 9 | 208.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2019-03-24 |